Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Parkinson's Disease
NCT03858270Phase 3Unknown
- Sponsor
- Wayne State University
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Memantine with Placebo (2 arms). Primary endpoints: Rey Auditory Verbal Learning Test at 1 year, Trail Making Test at 1 year and 2 more. Status: unknown.
02
Drugs
memantine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03858270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03858270.